Moonwalk Biosciences operates a genomic medicine company that aims to provide a new class of precision epigenetic medications.
Moonwalk Biosciences has raised $57.0M in total funding. The most recent round was Series A. The last funding was announced in January 2024.
Moonwalk Biosciences's investors include Khosla Ventures, ARCH Venture Partners, Alpha Wave Global, Future Ventures, Google Ventures.
Moonwalk Biosciences is headquartered in San Francisco, United States.
Moonwalk Biosciences operates a genomic medicine company that aims to provide a new class of precision epigenetic medications.
Moonwalk Biosciences is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Moonwalk Biosciences — Funding & Investors." VCBacked, January 4, 2024, https://www.vcbacked.co/company/moonwalk-biosciences. Accessed July 19, 2026.
VCBacked. (2024). Moonwalk Biosciences — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/moonwalk-biosciences
{{cite web |title=Moonwalk Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/moonwalk-biosciences |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated